CFO interim
The Goodyear Tire & Rubber Company names Scott M. Deakin interim CFO
The Goodyear Tire & Rubber Company reported in a Form 8-K filed June 26, 2026 that Scott M. Deakin was named Interim Executive Vice President and Chief Financial Officer, effective July 1, 2026.
In the filing's words
In connection with Ms. Zamarro’s departure, the Company announced that Scott M. Deakin, 60, will be appointed as Interim Executive Vice President and Chief Financial Officer, effective July 1, 2026, while the Company conducts a comprehensive search to identify Ms. Zamarro’s successor.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | The Goodyear Tire & Rubber Company (GT) |
|---|---|
| Event | Interim |
| Incoming | Scott M. Deakin |
| Outgoing | Christina L. Zamarro |
| Title in the filing | Interim Executive Vice President and Chief Financial Officer |
| Effective | July 1, 2026 |
| 8-K filed | June 26, 2026 |
| Internal promotion | No |
| Prior role (per filing) | chief financial officer, Gypsum Management & Supply, Inc. |
| SEC CIK | 0000042582 |
The Goodyear Tire & Rubber Company reported this change in a Form 8-K, Item 5.02, filed June 26, 2026. The filing's own words are quoted above.
Before and after at The Goodyear Tire & Rubber Company
The adjacent records in the company's seat timeline.
Other records naming Christina L. Zamarro
1The outgoing officer on this record, matched by name. Career line.
2026-02-10 · 10-K signature
Christina L. Zamarro signed The Goodyear Tire & Rubber Company's annual report as Executive Vice President and Chief Financial Officer (Principal Financial Officer)
Other records naming Scott M. Deakin
1The incoming officer on this record, matched by name. Career line.
2 weeks ago· 2026-10-27TransitionGT
The Goodyear Tire & Rubber Company CFO transition: Jerome J. Rouquet to succeed Scott M. Deakin
Also filed in June 2026
Other CFO moves on the record that month. All moves.
4 months ago· 2026-06-30TransitionBANX
ArrowMark Financial Corp. CFO transition: Katherine Jones to succeed Patrick Farrell
4 months ago· 2026-06-30InterimIMNN
Imunon, Inc. names Josh Blacher interim CFO
4 months ago· 2026-06-30TransitionRANI
Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford
4 months ago· 2026-06-29InterimCVKD
Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO
4 months ago· 2026-06-29TransitionGCO
Genesco Inc. CFO transition: Jonathan Collins to succeed Mimi E. Vaughn
4 months ago· 2026-06-29TransitionTNYA
Tenaya Therapeutics, Inc. CFO transition: Eric Hyllengren, M.B.A. to succeed Faraz Ali, M.B.A.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Scott M. Deakin? Send a correction with the primary source.